메뉴 건너뛰기
Expert Opinion on Biological Therapy
Volumn 12, Issue 6, 2012, Pages 659-661
CIK cells - Current status, clinical perspectives and future prospects the good news
Author keywords

Adoptive immunotherapy; Cancer; Cytokine induced killer; Solid tumors
Indexed keywords

CD3 ANTIBODY; GAMMA INTERFERON; HLA ANTIGEN; INTERLEUKIN 2; NATURAL KILLER CELL RECEPTOR NKG2D;
EID: 84861324341     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.2012.676037     Document Type: Review
Times cited : (25)
References (8)
  • 1
    • 77951691641 scopus 로고    scopus 로고
    • Cytokine-induced NK-like T cells: From bench to bedside
    • Article ID 435745)
    • Linn YC, Hui KM. Cytokine-induced NK-like T cells: From bench to bedside. J Biomed Biotechnol 2010;1-8 (Article ID 435745)
    • (2010) J. Biomed. Biotechnol. , pp. 1-8
    • Linn, Y.C.1    Hui, K.M.2
  • 2
    • 80053210017 scopus 로고    scopus 로고
    • Adoptive immunotherapy with cytokine-induced killer cells for patients with relapsed hematologic malignancies after allogeneic hematopoietic cell transplantation
    • Laport GG, Sheehan K, Baker J, et al. Adoptive immunotherapy with cytokine-induced killer cells for patients with relapsed hematologic malignancies after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2011;17:1679-1687
    • (2011) Biol. Blood Marrow. Transplant , vol.17 , pp. 1679-1687
    • Laport, G.G.1    Sheehan, K.2    Baker, J.3
  • 3
    • 84861327182 scopus 로고    scopus 로고
    • Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors
    • Mesiano G, Todorovic M, Gammaitoni L, et al. Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors. Expert Opin Biol Ther 2012;12(6):673-684
    • (2012) Expert Opin Biol. Ther. , vol.12 , Issue.6 , pp. 673-684
    • Mesiano, G.1    Todorovic, M.2    Gammaitoni, L.3
  • 4
    • 33645690747 scopus 로고    scopus 로고
    • Enhanced killing of primary ovarian cancer by retargeting autologous cytokine-induced killer cells with bispecific antibodies: A preclinical study
    • Chan JK, Hamilton CA, Cheung MK, et al. Enhanced killing of primary ovarian cancer by retargeting autologous cytokine-induced killer cells with bispecific antibodies: A preclinical study. Clin Cancer Res 2006;12:1859-1867
    • (2006) Clin. Cancer Res. , vol.12 , pp. 1859-1867
    • Chan, J.K.1    Hamilton, C.A.2    Cheung, M.K.3
  • 5
    • 84859570163 scopus 로고    scopus 로고
    • New adoptive immunotherapy strategies for solid tumours with CIK cells
    • Thanendrarajan S, Kim Y, Schmidt-Wolf I. New adoptive immunotherapy strategies for solid tumours with CIK cells. Expert Opin Biol Ther 2012;12:565-572
    • (2012) Expert Opin. Biol. Ther. , Issue.12 , pp. 565-572
    • Thanendrarajan, S.1    Kim, Y.2    Schmidt-Wolf, I.3
  • 6
    • 19444383219 scopus 로고    scopus 로고
    • Comparative gene expression profiling of cytokine-induced killer cells in response to acute myloid leukemic and acute lymphoblastic leukemic stimulators using oligonucleotide arrays
    • Linn YC, Wang SM, Hui KM. Comparative gene expression profiling of cytokine-induced killer cells in response to acute myloid leukemic and acute lymphoblastic leukemic stimulators using oligonucleotide arrays. Exp Hematol 2005;33:671-668
    • (2005) Exp. Hematol. , vol.33 , pp. 671-668
    • Linn, Y.C.1    Wang, S.M.2    Hui, K.M.3
  • 7
    • 59449109417 scopus 로고    scopus 로고
    • Characterization of the recognition and functional heterogeneity exhibited by cytokine-induced killer cell subsets against acute myeloid leukaemia target cell
    • Linn YC, Kee S, Lau J, et al. Characterization of the recognition and functional heterogeneity exhibited by cytokine-induced killer cell subsets against acute myeloid leukaemia target cell. Immunology 2009;126:423-435
    • (2009) Immunology , vol.126 , pp. 423-435
    • Linn, Y.C.1    Kee, S.2    Lau, J.3
  • 8
    • 78751628167 scopus 로고    scopus 로고
    • Clinical trials on CIK cells: First report of the international registry on CIK cells (IRCC)
    • Hontscha C, Borck Y, Zhou H, et al. Clinical trials on CIK cells: First report of the international registry on CIK cells (IRCC). J Cancer Res Clin Oncol 2011;137:305-310
    • (2011) J. Cancer Res. Clin. Oncol. , vol.137 , pp. 305-310
    • Hontscha, C.1    Borck, Y.2    Zhou, H.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.